we evaluated therapeutic usefulness of the second-generation sulfonylurea agents glyburide and glipizide in non-insulin-dependent diabetic patients who were secondary failures on chlorpropamide or tolazamide .
C0011860
non-insulin-dependent diabetic
C0008287
chlorpropamide